ArticleOncoscience2016

In silico and experimental analyses predict the therapeutic value of an EZH2 inhibitor GSK343 against hepatocellular carcinoma through the induction of metallothionein genes.

Tsang-Pai Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.